Blog

Insistence of Deflazacort in therapeutic market (Q3, 2019)

MedAnalytics

MedAnalytics defines market demand by measuring the quantity of a generic that required for clinical management for a given time period.It also speculates a market size within the therapeutic class and validates a plan of a product in business consideration based on current and potential market demand.In Q4, 2016 to Q3 2019, Deflazacort market demand increased at 14.93% CAGR. While demand for others changed: Prednisolone at 1% CAGR, Hydrocortisone at -2.09% CAGR, Dexamethasone Sodium Phosphate at 2.85% CAGR, Dexamethasone at -2.66% CAGR, Triamcinolone Acetonide at 0.14% CAGR, Methylprednisolone at 1.06% CAGR, Methylprednisolone Sodium Succinate at -6.88% CAGR, Betamethasone at 10.86% CAGR and Methylprednisolone Acetate at 0.82% CAGR.Over the forecast period of 2020 - 2022, Deflazacort market demand is expected to increase at 11.77% CAGR. While demand for others are expected to change: Prednisolone at 1.06% CAGR, Hydrocortisone at -1.88% CAGR, Dexamethasone Sodium Phosphate at -0.42% CAGR, Dexamethasone at -6.35% CAGR, Triamcinolone Acetonide at -0.65% CAGR, Methylprednisolone at 4.78% CAGR, Methylprednisolone Sodium Succinate at -5.29% CAGR, Betamethasone at 7.95% CAGR and Methylprednisolone Acetate at 3.57% CAGR.

You might be interested to